Impact of Inflammation on Myeloproliferative Neoplasm Symptom Development

por Geyer, Holly L., Dueck, Amylou C., Scherber, Robyn M., Mesa, Ruben A.
Publicado 2015

The Critical Role of Inflammation in the Pathogenesis and Progression of Myeloid Malignancies

por Craver, Brianna M., El Alaoui, Kenza, Scherber, Robyn M., Fleischman, Angela G.
Publicado 2018

Trends in overall mortality among US veterans with primary myelofibrosis

por Tashi, Tsewang, Yu, Jingbo, Pandya, Shivani, Dieyi, Christopher, Scherber, Robyn, Parasuraman, Shreekant
Publicado 2023

Cytoreductive treatment patterns among US veterans with polycythemia vera

por Parasuraman, Shreekant, Yu, Jingbo, Paranagama, Dilan, Shrestha, Sulena, Wang, Li, Baser, Onur, Scherber, Robyn
Publicado 2018

Hematocrit levels and thrombotic events in patients with polycythemia vera: an analysis of Veterans Health Administration data

por Parasuraman, Shreekant, Yu, Jingbo, Paranagama, Dilan, Shrestha, Sulena, Wang, Li, Baser, Onur, Scherber, Robyn
Publicado 2019

Body Mass Index and Total Symptom Burden in Myeloproliferative Neoplasms Discovery of a U-shaped Association

por Christensen, Sarah Friis, Scherber, Robyn Marie, Brochmann, Nana, Goros, Martin, Gelfond, Jonathan, Andersen, Christen Lykkegaard, Flachs, Esben Meulengracht, Mesa, Ruben
Publicado 2020

Ruxolitinib Re-Treatment in Patients with Myelofibrosis: Real-World Evidence on Patient Characteristics and Outcomes

por Gerds, Aaron T., Yu, Jingbo, Scherber, Robyn M., Paranagama, Dilan, Kish, Jonathan K., Visaria, Jay, Singhal, Mukul, Verstovsek, Srdan, Pemmaraju, Naveen
Publicado 2022

Quality of life and disease understanding: impact of attending a patient-centered cancer symposium

por Padrnos, Leslie, Dueck, Amylou C, Scherber, Robyn, Glassley, Pamela, Stigge, Rachel, Northfelt, Donald, Mikhael, Joseph, Aguirre, Annette, Bennett, Robert M, Mesa, Ruben A
Publicado 2015

Tobacco use in the Myeloproliferative neoplasms: symptom burden, patient opinions, and care

por Christensen, Sarah F., Scherber, Robyn M., Mazza, Gina L., Dueck, Amylou C., Brochmann, Nana, Andersen, Christen L., Hasselbalch, Hans C., Mesa, Ruben A., Geyer, Holly L.
Publicado 2021

Development of a symptom assessment in patients with myelofibrosis: qualitative study findings

por Mesa, Ruben A., Su, Yun, Woolfson, Adrien, Prchal, Josef T., Turnbull, Kathleen, Jabbour, Elias, Scherber, Robyn, Shields, Alan L., Krohe, Meaghan, Ojo, Funke, Pompilus, Farrah, Cappelleri, Joseph C., Harrison, Claire
Publicado 2019

Depressive symptoms and myeloproliferative neoplasms: Understanding the confounding factor in a complex condition

por Padrnos, Leslie, Scherber, Robyn, Geyer, Holly, Langlais, Blake T., Dueck, Amylou C., Kosiorek, Heidi E., Senyak, Zhenya, Clark, Matthew, Boxer, Michael, Cotter, Mary, Harrison, Claire, Stonnington, Cynthia, Geda, Yonas, Mesa, Ruben
Publicado 2020

The NUTRIENT Trial (NUTRitional Intervention among myEloproliferative Neoplasms): Feasibility Phase

por Mendez Luque, Laura F., Avelar-Barragan, Julio, Nguyen, Hellen, Nguyen, Jenny, Soyfer, Eli M., Liu, Jiarui, Chen, Jane H., Mehrotra, Nitya, Kosiorek, Heidi E., Dueck, Amylou, Himstead, Alexander, Heide, Elena, Lem, Melinda, Alaoui, Kenza El, Marin, Eduard Mas, Scherber, Robyn M., Mesa, Ruben A., Whiteson, Katrine L., Odegaard, Andrew, Fleischman, Angela G.
Publicado 2023

Impact of COVID19 Pandemic on an International MPN Patient Population: Survey Results from 1560 MPN Patients

por Palmer, Jeanne M., Mead-Harvey, Carolyn, Harrison, Claire, Dueck, Amylou C., Eckert, Ryan, Kosiorek, Heidi E., Muxi, Pablo, Pemmaraju, Naveen, Ruiz Arguelles, Guillermo, Vannucchi, Alessandro M., Gupta, Vikas, Mascarenhas, John, Taylor, Kerry, Gowin, Krisstina L., Geyer, Holly L., Shimoda, Kazuya, Kiladjian, Jean-Jacques, Komatsu, Norio, Kam Li Shan, Grace, Abello, Virginia, Gomez-Almaguer, David, Scherber, Robyn M., Jiang, Qian, Zuo, Xuelan, Huberty, Jennifer, Anderson, Lesley, Langlais, Blake T., Brazeau, Ann, Woehrle, Michelle, Mauro, Michael J., Mesa, Ruben
Publicado 2020

P1017: REDUCTIONS IN INDOLENT SYSTEMIC MASTOCYTOSIS BIOMARKER BURDEN WITH AVAPRITINIB IN THE REGISTRATIONAL, DOUBLE-BLIND PLACEBO-CONTROLLED PIONEER TRIAL

por Gotlib, Jason, Castells, Mariana, Oude Elberink, Hanneke, Siebenhaar, Frank, Hartmann, Karin, Broesby-Olsen, Sigurd, George, Tracy I., Panse, Jens, Alvarez-Twose, Ivan, Radia, Deepti, Tashi, Tsewang, Bulai Livideanu, Cristina, Sabato, Vito, Van Daele, Paul, Cerquozzi, Sonia, Dybedal, Ingunn, Reiter, Andreas, Ustun, Celalettin, Schafhausen, Philippe, Bose, Prithviraj, Deangelo, Daniel J., Rein, Lindsay, Vachhani, Pankit, Triggiani, Massimo, Rafferty, Mark, Butt, Nauman, Oh, Stephen, Wortmann, Friederike, Ungerstedt, Johanna, Taparia, Minakshi, Kuykendall, Andrew T., Arana Yi, Cecilia, Mattsson, Mattias, Shomali, William, Giannetti, Matthew, Bidollari, Ilda, Lin, Hui-Min, Scherber, Robyn, Roche, Maria, Akin, Cem, Maurer, Marcus
Publicado 2023